跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 3,754 条关于
“HWK-016”
全部
3,754
临床试验
1,573
药物
1,873
机构
54
资讯
254
8个月前
Whitehawk Therapeutics Advances Two Next-Generation ADCs into Clinical Trials with FDA IND Clearances
5天前
Whitehawk Data at WCLC 2026 Position PTK7 as Durable, Treatment-Agnostic ADC Target in EGFR Wild-Type NSCLC
6个月前
BrYet Files IND Application for ML-016 Oncology Therapy Targeting Advanced Solid Tumors
3个月前
Whitehawk Therapeutics Validates SEZ6 as High-Expression Target for Small Cell Lung Cancer ADC Development
11个月前
Whitehawk Therapeutics Validates PTK7 as Third Most Abundant ADC Target Across 157,000 Tumor Samples
2年前
ProKidney Prioritizes US Market for Rilparencel, Discontinuing Ex-US Phase III CKD Trial
10个月前
BrYet US Secures Patent for Nanoporous Silicon Drug Delivery Platform Targeting Cancer Treatment Resistance
去年
Telotristat Ethyl Shows Promise in Managing Weight Loss for Metastatic Pancreatic Cancer Patients
去年
Acalabrutinib Receives FDA Approval for Previously Untreated Mantle Cell Lymphoma
去年
Cell and Gene Therapies Show Promise in Treating Diabetes and Related Complications
第 1 页,共 26 页
上一页
下一页